Integer Holdings (ITGR) Cash from Investing Activities Growth (1y) (2011 - 2026)
Integer Holdings (ITGR) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -208.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -397.90% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -514.25% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -187.82% |
| 10 | Integer Holdings | 3.40 Bn | 3.40 Bn | 109.60 Mn | 80.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 80.78% |
| Dec 31, 2025 | -219.76% |
| Sep 26, 2025 | 22.74% |
| Jun 27, 2025 | 41.74% |
| Mar 28, 2025 | -17.22% |
| Dec 31, 2024 | 136.75% |
| Sep 27, 2024 | -3.21% |
| Jun 28, 2024 | 6.35% |
| Mar 29, 2024 | -581.13% |
| Dec 31, 2023 | -157.26% |
| Sep 29, 2023 | -24.37% |
| Jun 30, 2023 | 76.37% |
| Mar 31, 2023 | -137.49% |
| Dec 31, 2022 | 87.02% |
| Sep 30, 2022 | -82.02% |
| Jul 1, 2022 | -1,185.43% |
| Apr 1, 2022 | -36.01% |
| Dec 31, 2021 | -1,972.90% |
| Oct 1, 2021 | -25.07% |
| Jul 2, 2021 | 12.99% |